Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers
Lomond Therapeutics Holdings, Inc.
Lomond Therapeutics Holdings, Inc.
Ipsen
Hospital Universitario Dr. Jose E. Gonzalez
Jonsson Comprehensive Cancer Center
Janssen Korea, Ltd., Korea
Janssen Korea, Ltd., Korea
Zhejiang University
Fred Hutchinson Cancer Center